Adenosine, by acting on adenosine A 1 and A 2A receptors, is known to antagonistically modulate dopaminergic neurotransmission. We have recently reported that nonselective adenosine receptor antagonists (caffeine and 3,7-dimethyl-1-propargylxanthine) can partially substitute for the discriminativestimulus effects of methamphetamine. In the present study, by using more selective compounds, we investigated the involvement of A 1 and A 2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of both cocaine and methamphetamine. The effects of the A 1 receptor agonist N 6 -cyclopentyladenosine (CPA; 0.01-0.1 mg/kg) and antagonist 8-cyclopentyl-1,3-dimethylxanthine (CPT; 1.3-23.7 mg/kg) and the A 2A receptor agonist 2-p-(2-carboxyethyl)phenethylamino-5Ј-N-ethylcarboxamidoadenosine hydrochloride (CGS 21680; 0.03-0.18 mg/kg) and antagonist 3-(3-hydroxypropyl)-8-(3-methoxystyryl)-7-methyl-1-propargylxanthin phosphate disodium salt (MSX-3; 1-56 mg/kg) were evaluated in rats trained to discriminate either 1 mg/kg methamphetamine or 10 mg/kg cocaine from saline under a fixed-ratio 10 schedule of food presentation. The A 1 and A 2A receptor antagonists (CPT and MSX-3) both produced high levels of drug-lever selection when substituted for either methamphetamine or cocaine and significantly shifted dose-response curves of both psychostimulants to the left. Unexpectedly, the A 2A receptor agonist CGS 21680 also produced drug-appropriate responding (although at lower levels) when substituted for the cocaine-training stimulus, and both CGS 21680 and the A 1 receptor agonist CPA significantly shifted the cocaine dose-response curve to the left. In contrast, both agonists did not produce significant levels of drug-lever selection when substituted for the methamphetamine-training stimulus and failed to shift the methamphetamine dose-response curve. Therefore, adenosine A 1 and A 2A receptors appear to play important but differential roles in the modulation of the discriminative-stimulus effects of methamphetamine and cocaine.
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S(ϩ)-methylamphetamine hydrochloride (methamphetamine) and cocaine are powerful addictive psychomotor stimulants, and their subjective effects, together with their reinforcing effects, contribute to the abuse liability of these drugs and can be studied in animals using drug-discrimination procedures (Colpaert, 1986) . Increased dopaminergic neurotransmission appears to be a main mechanism mediating the discriminative-stimulus effects of both methamphetamine (Sasaki et al., 1995; Tidey and Bergman, 1998; Munzar and Goldberg, 2000) and cocaine (Baker et al., 1993; Caine et al., 2000; Howell et al., 2000) , although there is evidence for the involvement of nondopaminergic systems (e.g., Kuczenski et al., 1995; Munzar and Goldberg, 1999; Mori et al., 2002; Munzar et al., 2002b) . Although methamphetamine and cocaine have similar behavioral effects and similar effects on dopaminergic neurotransmission, their neurochemical mechanisms of action are different. Methamphetamine facilitates the release of dopamine, norepinephrine, and serotonin from nerve terminals (e.g., Kuczenski et al., 1995) , whereas co-caine binds to monoamine transporters and inhibits synaptic dopamine, norepinephrine, and serotonin reuptake (for a review, see Uhl et al., 2002) . Furthermore, there is evidence suggesting that cocaine, but not d-amphetamine, increases cerebral extracellular levels of adenosine (Herrera-Marschitz et al., 1994; Fiorillo and Williams, 2000) .
Antagonistic and reciprocal interactions are known to exist between different subtypes of adenosine and dopamine receptors in the brain (Ferré et al., 1997) . Adenosine A 1 receptors are colocalized with dopamine D 1 receptors, and adenosine A 2A receptors are colocalized with dopamine D 2 receptors and form functional heteromeric complexes (Gines et al., 2000; Hillion et al., 2002) . In general, stimulation of adenosine receptors counteracts the behavioral effects of dopamine receptor stimulation (Ferré et al., 1997) . Accordingly, adenosine receptor agonists counteract, whereas adenosine receptor antagonists potentiate, the pharmacological effects of psychostimulants like cocaine and amphetamines (Heffner et al., 1989; Popoli et al., 1994; Rimondini et al., 1997; Malec, 2000, 2002; Shimazoe et al., 2000; Knapp et al., 2001) . Therefore, the discriminative-stimulus effects of cocaine and the analog of d-amphetamine methamphetamine should be altered by agents acting at adenosine receptors. In a recent report, we suggested that A 2A receptors play a more important role than A 1 receptors in adenosinemediated modulation of the discriminative-stimulus effects of methamphetamine (Munzar et al., 2002a) . However, this interpretation was based on results obtained with the A 1 receptor antagonist DPCPX and the two nonselective A 2A antagonists, caffeine and 3,7-dimethyl-1-propargylxanthine. Moreover, the role of A 1 and A 2A adenosine receptors in the discriminative-stimulus effects of cocaine is still unknown.
The aim of the present study was to compare involvement of adenosinergic receptors in the discriminative-stimulus effects of cocaine and methamphetamine. We characterized the role of A 1 and A 2A receptors in the adenosinergic modulation of the discriminative-stimulus effects of psychostimulants by studying the ability of selective adenosine A 1 and A 2A receptor agonists [N 6 -cyclopentyladenosine (CPA) and 2-p-(2-carboxyethyl)phenethylamino-5Ј-N-ethylcarboxamidoadenosine hydrochloride (CGS 21680), respectively] and adenosine A 1 and A 2A receptor antagonists [8-cyclopentyl-1,3-dimethylxanthine (CPT) and 3-(3-hydroxypropyl)-8-(3-methoxystyryl)-7-methyl-1-propargylxanthin phosphate disodium salt (MSX-3), respectively] to mimic or modulate the discriminative-stimulus effects of both methamphetamine and cocaine in rats.
Materials and Methods
Subjects. Male Sprague-Dawley rats (Charles River Laboratories, Inc., Wilmington, MA), experimentally naive at the start of the study and initially weighing 290 to 350 g, were housed individually. The rats were allowed 7 days of free feeding after being delivered to the animal facility. Before the start of the study, rats were diet restricted (3 NIH07 biscuits/day) for 10 days (weight was 270 -340 g at the start of the study), and the diet restriction was maintained throughout the study. Enrichments (fresh fruits and vegetables) were provided on Saturdays. Water was available ad libitum. All rats were housed in a temperature-and humidity-controlled room and were maintained on a 12-h light/dark cycle (lights on from 7 AM to 7 PM). Experiments were conducted during the light phase. Animals used in this study were maintained in facilities fully accredited by the American Association for the Accreditation of Laboratory Animal Care, and all experimentation was conducted in accordance with the guidelines of the Institutional Care and Use Committee of the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, and the Guide for Care and Use of Laboratory Animals (National Research Council 1996) .
Apparatus. Twelve standard operant-conditioning chambers (Coulbourn Instruments, Allentown, PA) were used. Each chamber contained a white house light and two levers, separated by a recessed tray into which a pellet dispenser could deliver 45-mg food pellets (F0021; Bioserv, Frenchtown, NJ). Each press of a lever with force of 0.4 N through 1 mm was recorded as a response and was accompanied by an audible click. The operant-conditioning chambers were controlled by microcomputers using the MED Associates MED-PC software package (MED Associates, St. Albans, VT).
Drug-Discrimination Procedure. Rats were trained as described previously (Yasar et al., 1994; Munzar and Goldberg, 1999) under a discrete-trial schedule of food-pellet delivery to respond on one lever after an injection of a training dose of 1 mg/kg methamphetamine (n ϭ 18) or 10 mg/kg cocaine (n ϭ 12) and on the other lever after an injection of 1 ml/kg saline vehicle. Injections of methamphetamine, cocaine, or saline were given intraperitoneally 15 min before the start of the session. At the start of the session, a white house light was turned on, and in its presence, the rats were required to make 10 consecutive responses (fixed-ratio 10 schedule of food delivery) on the lever appropriate to the presession treatment. The completion of 10 consecutive responses on the correct lever produced delivery of a 45-mg food pellet and initiated a 45-s timeout during which lever-press responses had no programmed consequences and the chamber was dark. Responses on the incorrect lever had no programmed consequences other than to reset the fixed-ratio requirement on the correct lever. After each timeout, the white house light was again turned on, and the next trial began. Each session ended after completion of 20 fixed-ratio trials or after 30 min elapsed, whichever occurred first. Discrimination-training sessions were conducted 5 days per week under a double alternation schedule (i.e., DDSSDDSS etc., where D ϭ drug and S ϭ saline). Training continued until there were eight consecutive sessions during which rats completed at least 90% of their responses during the session on the correct lever and no more than four responses occurred on the incorrect lever during the first trial. Test sessions with other doses and other drugs were then initiated.
During test sessions, a range of doses of different adenosinergic compounds were substituted for the training dose of methamphetamine or cocaine. Adenosine receptor agonists were also administered together with training doses of these psychostimulants to assess possible alteration of their discriminative-stimulus effects. Subsequently, the effects of selected doses of adenosinergic compounds on the methamphetamine and cocaine dose-response curves were established. Methamphetamine and cocaine dose-response curves were first determined after the discrimination was acquired before testing other drugs and were redetermined three times in each subject. The last determination was performed after completion of testing of all pretreatments on both dose-response curves. Test sessions were identical to training sessions, with the exception that 10 consecutive responses on either one of the two levers ended the trial. Switching responding from one lever to the other lever reset the ratio requirement. In a test phase, a single alternation schedule was introduced, and test sessions were usually conducted on Tuesdays and Fridays. Thus, a 2-week sequence starting on Monday was: DTSDTSTDST (T ϭ test). In this way, test sessions occurred with equal probability after saline and drug sessions. Test sessions were conducted only if the criterion of 90% accuracy and not more than four incorrect responses during the first trial was maintained in the two preceding training sessions.
Drugs. Methamphetamine, adenosine A 1 receptor agonist CPA, adenosine A 1 receptor antagonist CPT, and adenosine A 2A receptor agonist CGS 21680 were purchased from Sigma-Aldrich (St. Louis, MO). Adenosine A 2A receptor antagonist MSX-3 was synthesized at the Pharmaceutical Institute, University of Bonn, Germany. (Ϫ)-Cocaine HCl was obtained from the National Institute on Drug Abuse, National Institutes of Health (Rockville, MD).
Doses of methamphetamine, cocaine, MSX-3, and CGS 21680 refer to the weight of the salt, whereas doses of CPT and CPA refer to the weight of the drug. One milligram of the salt form of MSX-3 is equivalent to 0.74 mg of base, and 1 mg of CGS 21680 is equivalent to 0.93 mg of base. All drugs were dissolved in saline (0.9% NaCl) with a minimal amount of 1 N NaOH for MSX-3 and CPT (final pH 7.4) and sonicated or slightly heated (CGS 21680) if needed. Most drugs were injected in a volume of 1.0 ml/kg. The highest tested doses of CPT (13.3 and 23.7 mg/kg) and MSX-3 (30 and 56 mg/kg) were injected in a volume of 2 or 3 ml/kg due to solubility constraints. All drugs were administered intraperitoneally.
A range of doses of each drug was tested in the drug-discrimination study, and dose was increased until there was either complete substitution for the methamphetamine-or cocaine-training stimulus or until the test drug produced a significant decrease in response rates. Effects of adenosine antagonists alone were tested first followed by testing of the effects of selected doses of each antagonist (and their vehicle) on the methamphetamine and cocaine dose-response curves. After completing studies with adenosinergic antagonists, the adenosinergic agonists were tested alone and then in combination with the training dose of methamphetamine or cocaine. Finally, selected doses of each agonist were then tested in combination with different doses of methamphetamine or cocaine to assess possible alterations in dose-response curves (combination tests). Not all of the compounds were tested in all subjects. Generally, CPA and CPT or CGS 21680 and MSX-3 were tested in the same subjects.
Injections of methamphetamine, cocaine, or saline were given 15 min before the start of the session. Due to their quick initial effect, a short time interval (from 0 -15 min) is usually used to study the ability of systemically administered CPA, CGS 21680, CPT, or MSX-3 to modulate the effects of psychostimulants or other centralacting substances (Rimondini et al., 1997; Malec, 2000, 2002; Karcz-Kubicha et al., 2003) . In generalization tests, the adenosine agonists and antagonists were administered 10 min before the session. In combination tests, all tested compounds were administered 10 min before methamphetamine or cocaine (i.e., 25 min before the session). Immediately preceding all combination tests, the selected dose of each of the adenosinergic compounds and also its vehicle was administered 10 min before saline (i.e., 25 min before the session) to obtain proper controls for assessment of the interactions during combination tests (additive versus superadditive effects; see Figs. 2, 3, 5, and 6) .
Data Analysis. Discriminative-stimulus data were expressed as the percentage of the total responses on both levers that were made on the methamphetamine-or cocaine-appropriate lever. Complete substitution for the methamphetamine training dose was defined as 90% or more of responses on the methamphetamine-appropriate lever, whereas no generalization was defined as less than 20% of responses on the methamphetamine-or cocaine-appropriate lever. Response-rate data were expressed as responses per second averaged over the session, with responding during timeout periods not included in calculations. The data from sessions during which rats did not complete at least one fixed ratio were excluded from analysis of drug-lever selection. All results are presented as group means Ϯ S.E. values.
Statistical analysis of generalization and pretreatment tests was done by using one-way ANOVA for repeated measures. Significant main effects were analyzed further by subsequent paired comparisons with vehicle control (responding after vehicle injections in substitution tests or after vehicle pretreatment in tests with training stimuli) using post hoc Dunnett's test. ED 50 values and 95% confidence intervals (CIs) for methamphetamine and cocaine dose-response curves after different pretreatments were calculated by linear regression using three or four points on the ascending portions of the dose-response curves. The A 50 values and 95% confidence intervals were calculated for each antagonist by fitting the data to a sigmoidal dose-response equation using Prism3 software (GraphPad Software Inc., San Diego, CA).
As dose-response curves were not always parallel, dose-response curves were further evaluated by using two-way ANOVA for repeated measures. Shifts in dose-response curves were considered significant only if 95% CIs did not overlap and if two-way ANOVA for repeated measures revealed significant difference (p Ͻ 0.05). To evaluate whether the drug combinations produced simple additive or superadditive effects, theoretically additive values were individually calculated for each rat (as described in our previous reports, Munzar et al., 2002a,b) and compared with experimental values actually obtained. Theoretically additive values were calculated by adding the effect of each pretreatment drug when administered alone to the effects of each dose of methamphetamine or cocaine when administered together with the vehicle. Since 100% was the maximal achievable value, all sums greater than 100% were adjusted to this value. Changes were considered significant when p Ͻ 0.05. The SigmaStat program (SPSS Inc., Chicago, IL) was used.
Results
Establishment of Discrimination Baseline. To reach the final level of accuracy (eight consecutive sessions with at least 90% of the responses on the correct lever and no more than four incorrect responses during the first trial) required 32 to 87 sessions with a mean value (ϮS.E.M.) of 61.28 Ϯ 3.47 sessions for methamphetamine-trained rats and 45 to 82 (59.5 Ϯ 3.24) sessions for cocaine-trained rats. Once the training criterion was reached, performance during maintenance training sessions was kept with high degree of accuracy (98 -100% responding on the appropriate lever). Rates of responding during the training sessions were stable across sessions during the whole study and were slightly lower after methamphetamine and cocaine than after saline pretreatment, as was observed in previous studies using the same 1.0 mg/kg training dose of methamphetamine (e.g., Goldberg, 1999, 2000) or 10.0 mg/kg training dose of cocaine (Munzar et al., 2002b) .
When the dose of methamphetamine was varied, there was a dose-dependent increase in drug-lever selection with maximal selection (99.91%) at the 1.0 mg/kg training dose of methamphetamine (one-way ANOVA for repeated measures; F 5,75 ϭ 101.70, p Ͻ 0.001; Fig. 1, left upper panel) . Similarly, when the dose of cocaine was varied, there was a dosedependent increase in drug-lever selection with maximal selection (99.79%) at the 10.0 mg/kg training dose of cocaine (F 5,55 ϭ 64.43, p Ͻ 0.001; Fig. 1, right upper panel) . The methamphetamine and cocaine dose-response curves remained stable throughout the study. The ED 50 values for dose-response curves calculated after stable discrimination performance was acquired and before the testing of other drugs (first test) were similar to the ED 50 values recalculated after testing of all pretreatments (last test), as revealed by overlapping 95% CIs (Table 1) .
Generalization Tests with Adenosine Receptor Antagonists. Figure 1 shows the percentage of responses made on the drug lever and overall rates of responding obtained during sessions when different doses of two adenosine antagonists were tested for their ability to substitute for the training dose 1 mg/kg of methamphetamine or 10 mg/kg of cocaine. The selective A 1 receptor antagonist CPT produced a partial, but statistically significant, substitution for both the methamphetamine-(F 6,66 ϭ 28.26, p Ͻ 0.001) and cocaine-(F 6,49 ϭ 13.68, p Ͻ 0.001) training stimuli at doses of 7.5, 13.3, and 23.7 mg/kg. A 50 values and 95% CIs for substitution for the methamphetamine-and cocaine-training stimuli were 7.38 (6.11-8.908 CI) mg/kg and 6.25 (3.11-12.58 CI) mg/kg, respectively. The level of drug-lever selection at the 13.3 mg/kg dose of CPT was about 65% in methamphetaminetrained rats and 75% in cocaine-trained rats. Increasing the dose of CPT to 23.7 mg/kg did not produce further increases in drug-lever selection in cocaine-trained animals and increased drug-lever selection by only about 10% in methamphetamine-trained rats, but it significantly decreased rates of responding to very low levels (one-way ANOVA for repeated measures; methamphetamine-trained rats: F 6,72 ϭ 16.07, p Ͻ 0.001; cocaine-trained rats: F 6,54 ϭ 20.77, p Ͻ 0.001), and 50% of the rats in each group failed to complete at least one fixed ratio (Fig. 1, bottom panels) .
The selective A 2A receptor antagonist MSX-3 also produced partial substitution for both the methamphetamine-and cocaine-training stimuli, although with lower potency than CPT. A 50 values and 95% CIs for substitution for the methamphetamine-and cocaine-training stimuli were 14.50 (5.47-38.45) mg/kg and 9.98 (4.98 -24.93) mg/kg, respectively. In methamphetamine-trained rats, MSX-3 produced significant substitution (F 5,37 ϭ 15.27, p Ͻ 0.001) for the methamphetamine-training stimulus only after high doses (30.0 and 56.0 mg/kg; Fig. 1, left panels) . The 56.0 mg/kg dose Fig. 1 . Left panels, effects of intraperitoneal pretreatment with methamphetamine (METH, n ϭ 16), CPT (n ϭ 13), or MSX-3 (n ϭ 9) in rats trained to discriminate 1.0 mg/kg methamphetamine from saline. Right panels, effects of intraperitoneal treatment with cocaine (n ϭ 12), CPT (n ϭ 10), or MSX-3 (n ϭ 8) in rats trained to discriminate 10.0 mg/kg cocaine from saline. Data are means Ϯ S.E. The percentage of responses on the lever associated with methamphetamine or cocaine administration is shown as a function of dose (mg/kg, log scale) during substitution test sessions (upper panels), and response rates are expressed as responses per second averaged over the session (bottom panels). ૺ, p Ͻ 0.05, ૺૺ, p Ͻ 0.01, post hoc comparison with the vehicle pretreatment after significant ANOVA for repeated-measures main effect, Dunnett's test. Numbers in parentheses at higher doses indicate the number of rats that completed at least one fixed ratio during the session over the total number of rats in which the dose was tested. of MSX-3 significantly decreased rates of responding (F 5,37 ϭ 6.38, p Ͻ 0.001). In cocaine-trained rats, MSX-3 produced partial substitution for the cocaine-training stimulus at doses of 10.0 and 30.0 mg/kg (F 4,28 ϭ 10.27, p Ͻ 0.001), with 30.0 mg/kg of MSX-3 significantly decreasing rates of responding (F 4,28 ϭ 7.77, p Ͻ 0.001; Fig. 1 , right panels). We were not able to test a higher dose of 56.0 mg/kg MSX-3 in this group due to limited availability of the substance. There is a possibility that MSX-3 would substitute completely for the cocaine-training stimulus at a dose of 56 mg/kg, since the level of cocaine-appropriate responding at the 30 mg/kg dose was 70% (compared with 60% in the methamphetamine group). However, increasing the dose of MSX-3 in the methamphetamine group of rats only increased the level of the substitution for the methamphetamine stimulus by 5%, so we would not expect a significant increase in generalization in the cocaine group either.
Effects of Pretreatments with Antagonists on Methamphetamine and Cocaine Dose-Response Curves. Figures 2 and 3 show effects of the A 1 receptor antagonist CPT and the A 2A receptor antagonist MSX-3 on methamphetamine (left panels) and cocaine (right panels) dose-response curves. ED 50 values for drug-lever selection with 95% CIs are presented in Table 1 . A 4.2-mg/kg dose of CPT, which did not produce significant substitution for the methamphetamineor cocaine-training stimuli and did not significantly change response rates when given alone, produced shifts to the left of both the methamphetamine and cocaine dose-response curves (Fig. 2) . These leftward shifts were significant as indicated by nonoverlapping 95% CIs of ED 50 values for vehicle and CPT pretreatments (Table 1) as well as by twoway ANOVA for repeated measures (methamphetamine: F 1,40 ϭ 23.86, p Ͻ 0.001; cocaine: F 1,24 ϭ 0.34, p Ͻ 0.001). The effect of CPT-methamphetamine and CPT-cocaine combinations were superadditive, since there was a statistically significant difference between the curves actually obtained and the calculated additive curves (methamphetamine: F 1,40 ϭ 17.68, p ϭ 0.002; cocaine: F 1,32 ϭ 44.63, p Ͻ 0.001).
Pretreatment with 10.0 mg/kg MSX-3 (dose chosen under the same criterion as dose of CPT) shifted the methamphetamine dose-response curve markedly to the left (Fig. 3) , as revealed by both nonoverlapping 95% CIs of ED 50 values (Table 1) and two-way ANOVA for repeated measures (F 1,24 ϭ 17.80, p Ͻ 0.001). The cocaine dose-response curve was also significantly shifted to the left by doses of 3.0 and 10.0 mg/kg of MSX-3 (Fig.  3) , as revealed by nonoverlapping 95% CIs of ED 50 values (Table 1) and two-way ANOVA for repeated measures (3.0 mg/kg: Generalization and Pretreatment Tests with Adenosine Receptor Agonists. Figure 4 shows the percentage of responses made on the drug lever and overall rates of responding when a range of doses of two selective adenosine receptor agonists were administered alone or together with the 1.0 mg/kg training dose of methamphetamine (left panels) or the 10.0 mg/kg training dose of cocaine (right panels). When the selective A 1 receptor agonist CPA was administered alone, no methamphetamine-lever selection was observed, even at doses of 0.03 and 0.1 mg/kg CPA, which significantly decreased response rates (3 of 7 rats did not complete a single fixed ratio; F 3,18 ϭ 15.82, p Ͻ 0.001). The high 0.1 mg/kg dose of CPA also did not produce significant substitution for the cocaine-training stimulus but markedly and significantly decreased response rates (2 of 7 rats did not complete a single fixed ratio; F 3,18 ϭ 25.56, p Ͻ 0.001).
The selective A 2A receptor agonist CGS 21680 did not produce substitution for the methamphetamine-training stimulus, even at the highest dose tested, 0.177 mg/kg, which markedly decreased response rates (2 of 6 rats did not complete a single fixed ratio; F 3,15 ϭ 6.12, p ϭ 0.006). However, CGS 21680 produced partial, but statistically significant (F 3,14 ϭ 4.31, p ϭ 0.024), substitution for the cocaine-training stimulus at doses of 0.1 and 0.177 mg/kg, which, however, produced significant decrease of response rates (F 3,15 ϭ 10.91, p Ͻ 0.001).
Neither CPA (0.01-0.1 mg/kg) nor CGS 21680 (0.03-0.177 mg/kg) significantly attenuated the discriminative-stimulus effects of training doses of either methamphetamine or cocaine (Fig. 4, upper panels) . However, doses of CPA 0.018 to 0.056 mg/kg produced small, but not significant, reductions in drug-lever selection (in 2 of the 7 cocaine-trained rats) when administered with the training dose of cocaine.
Effects of Pretreatments with Agonists on Methamphetamine and Cocaine Dose-Response Curves. Figures 5 and 6 show effects of the A 1 receptor agonist CPA and the A 2A receptor agonist CGS 21680 on methamphetamine (left panels) and cocaine (right panels) dose-response curves. ED 50 values for drug-lever selection with 95% CIs are presented in Table 1 .
The A 1 receptor agonist CPA produced different effects in the methamphetamine-versus the cocaine-trained rats. A 0.03-mg/kg dose of CPA, which did not produce substitution for the methamphetamine-or cocaine-training stimuli but produced a slight reduction in drug-lever selection when administered with the training doses of both methamphetamine and cocaine, did not produce any shift of the methamphetamine dose-response curve in the methamphetamine-trained rats ( Fig. 5 ; overlapping 95% CIs of the ED 50 values are shown in Table 1 ). In cocaine-trained rats, however, pretreatment with 0.03 mg/kg CPA shifted the cocaine dose-response curve markedly to the left (Fig. 5) , and the shift was significant according to nonover- Fig. 3 . Left panels, METH dose-response curves after intraperitoneal pretreatment with 1.0 ml/kg of vehicle or 3.0 mg/kg MSX-3 (n ϭ 9). Right panels, cocaine dose-response curves after pretreatment with 1.0 ml/kg of vehicle or 3.0 and 10.0 mg/kg MSX-3 (n ϭ 8). Data are expressed as mean Ϯ S.E. Other details are as described in Fig. 2. 
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lapping 95% CIs of the ED 50 values (Table 1) and two-way ANOVA for repeated measures (F 1,18 ϭ 15.045, p ϭ 0.008). The effect of the CPA-cocaine combination was clearly superadditive, since there was a statistically significant difference between values actually obtained and the calculated additive values (F 1,18 ϭ 17.11, p ϭ 0.006).
The A 2A agonist CGS 21680 also produced different effects in the methamphetamine-and cocaine-trained rats. A 0.056-mg/kg dose of CGS 21680, which did not produce significant substitution for the methamphetamine-or cocaine-training stimuli and did not significantly change response rates when given alone, did not produce any shift of the methamphetamine dose-response curve in methamphetamine-trained rats ( Fig. 6 ; overlapping 95% CIs of the ED 50 values are shown in Table 1 ). However, pretreatment with 0.056 mg/kg CGS 21680 shifted the cocaine dose-response curve markedly and significantly to the left (Fig. 6) , as revealed by nonoverlapping 95% CIs of the ED 50 values (Table 1) and two-way ANOVA for repeated measures (F 1,15 ϭ 11.86, p ϭ 0.018). The effect of the CGS 21680-cocaine combination was superadditive, since there was a statistically significant difference between values actually obtained and calculated additive values (F 1,15 ϭ 15.82, p ϭ 0.011).
Response rates after administration of a range of doses of both methamphetamine and cocaine were consistently decreased when the psychostimulants were administered in combination with 0.03 mg/kg of CPA or 0.056 mg/kg of CGS 21680. However, the effects reached statistical significance only in the methamphetamine-trained group (CPAmethamphetamine: F 1,20 ϭ 33.14, p ϭ 0.002; CGS 21680-methamphetamine: F 1,20 ϭ 8.41, p ϭ 0.034).
Discussion
The A 1 receptor antagonist CPT and the A 2A receptor antagonists MSX-3 significantly potentiated the discriminative-stimulus effects of methamphetamine and cocaine (shift of the dose-response curves for methamphetamine and cocaine to the left). Furthermore, both A 1 and A 2A receptor antagonists produced significant substitution for the drugtraining stimuli, i.e., they substituted for methamphetamine and cocaine in the stimulus-discrimination task. CPT is a xanthine-based adenosine receptor antagonist with an in vitro A 1 :A 2A receptor selectivity of about 100, as demonstrated in radioligand binding experiments in rat striatal and cortical membranes (Maemoto et al., 1997) . MSX-3 was developed as a phosphoric acid ester prodrug of MSX-2, with an in vitro A 2A :A 1 receptor selectivity of about 100, also demonstrated in rat striatal membranes . Both adenosine antagonists easily penetrate into the brain Fig. 4 . Left panels, effects of intraperitoneal pretreatment with CPA (n ϭ 7) and CGS 21680 (n ϭ 6) in rats trained to discriminate 1.0 mg/kg METH from saline. Right panels, effects of intraperitoneal pretreatment with CPA (n ϭ 7) and CGS 21680 (n ϭ 6) in rats trained to discriminate 10.0 mg/kg cocaine from saline. Data are means Ϯ S.E. The percentage of responses on the lever associated with methamphetamine or cocaine administration is shown as a function of dose (mg/kg, log scale) of adenosinergic compound administered alone (open symbols) or in combination with the training dose (filled symbols) of methamphetamine or cocaine (upper panels), and response rates are expressed as responses per second averaged over the session (bottom panels). Other details are as described in Fig. 1 .
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at ASPET Journals on October 25, 2017 jpet.aspetjournals.org after systemic administration (Baumgold et al., 1992; Muller et al., 2000) , and we have recently reported that the motoractivating effects of CPT and MSX-3 in rats are related to their selective blockade of A 1 and A 2A receptors, respectively (Karcz-Kubicha et al., 2003) . Thus, both CPT and MSX-3 produce motor activation at the same doses that selectively counteract motor depression induced by A 1 and A 2A receptor agonists, respectively (Karcz-Kubicha et al., 2003) . At motoractivating doses, MSX-3 produced partial substitution for both the methamphetamine-and cocaine-training stimuli, and there were no significant differences between methamphetamine-and cocaine-trained rats. These results confirm our previous suggestion that A 2A receptors play an important role in adenosine-mediated modulation of the discriminative stimulus effects of methamphetamine (Munzar et al., 2002a) and extend this finding to cocaine. Motor-activating doses of CPT also produced a partial substitution for both the methamphetamine-and cocaine-training stimuli, and there were no significant differences between methamphetamine-and cocaine-trained rats. The high level of partial substitution for both the methamphetamine-and cocaine-training stimuli produced by CPT implies that A 1 receptors are also directly involved in the discriminative-stimulus effects of these psychostimulants.
The present results are in disagreement with our previous conclusion that A 1 receptors play a less important role than A 2A receptors in adenosine-mediated modulation of the discriminative-stimulus effects of methamphetamine (Munzar et al., 2002a) , which was based on our previous findings that the A 1 receptor antagonist DPCPX did not produce any substitution for a methamphetamine-training stimulus but shifted the methamphetamine dose-response curve to the left. Both CPT and DPCPX are widely used selective A 1 receptor antagonists, with good penetration into the brain, and DPCPX has higher in vitro A 1 :A 2A receptor selectivity than CPT (about 4-fold higher; Maemoto et al., 1997) . However, a repeatedly reported differential behavioral effect of both antagonists is the lack of motor activation induced by DPCPX (reviewed in Karcz-Kubicha et al., 2003) . Our present and previous studies (Munzar et al., 2002a) show the existence of significant differences in the discriminativestimulus properties of CPT and DPCPX. Since the selective A 1 receptor antagonism of both compounds seems to be clearly established, these differences could be explained by the existence of an additional nonshared mechanism of action. In fact, DPCPX has been reported to bind with very high affinity to binding sites other than A 1 receptors, such as "nonstriatal atypical A 2A receptors" (atypical A 2A receptors; Cunha et al., 1996) and the cystic fibrosis transmembrane conductor regulator (Jacobson et al., 1995; Cohen et al., 1997) . Since both atypical A 2A receptors and cystic fibrosis transmembrane conductor regulator are expressed in the rat brain (Cunha et al., 1996; Johannesson et al., 1997) , they could therefore be involved in the unique profile responsible for the motor and discriminative-stimulus effects of DPCPX.
The involvement of A 1 and A 2A receptors in the adenosine- Fig. 5 . Left panels, METH dose-response curves after intraperitoneal pretreatment with 1.0 ml/kg of vehicle or 0.03 mg/kg CPA (n ϭ 6). Right panels, cocaine dose-response curves after pretreatment with 1.0 ml/kg of vehicle or 0.03 mg/kg CPA (n ϭ 7). Data are expressed as mean Ϯ S.E. Numbers in parentheses indicate the number of rats that completed at least one fixed ratio during the session over the total number of rats in which the combination was tested. Other details are as described in Fig. 2 . . The partial substitution produced by both adenosine antagonists is very likely mediated through enhancement of dopaminergic neurotransmission. It is known that at a presynaptic level, adenosine, mostly by acting on adenosine A 1 receptors localized in nerve terminals, inhibits dopamine and glutamate release (Okada et al., 1996; Flagmeyer et al., 1997; Golembiowska and Zylewska, 1997) . A recent study (Solinas et al., 2002) demonstrated that CPT, but not the selective A 2A receptor antagonist 5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e]-1,2,4-triazolo[1, 5-c]pyrimidine (SCH 58261), significantly increased extracellular levels of dopamine and glutamate (approximately 100% increases in both cases) in the shell of the nucleus accumbens. At a postsynaptic level, adenosine decreases dopaminergic neurotransmission via specific antagonistic interactions between adenosine and dopamine receptors (Ferré et al., 1991 (Ferré et al., , 1997 , suggesting that CPT (in addition to enhancing dopamine release) and MSX-3 can counteract an endogenous adenosine tone on central adenosine receptors, thus removing negative adenosinergic tone from D 1 and D 2 receptors, respectively, and mimicking the effects of psychostimulants. In the present experiments, we found CPT to be more potent than MSX-3 in producing substitution for both the methamphetamine-(2ϫ) and cocaine-training stimuli (1.5ϫ).
This is in contrast with their relative potencies as motor stimulants in the same rat strain, where MSX-3 is about twice as potent as CPT (Karcz-Kubicha et al., 2003) . The greater potency of the A 1 receptor antagonist at mimicking the discriminative-stimuli of methamphetamine and cocaine could be related to the ability of A 1 , but not A 2A , receptor antagonists to increase the extracellular concentration of dopamine (e.g., Solinas et al., 2002) . In view of the clear effects of adenosine antagonists described above, it was expected that adenosine agonists would not produce stimulant-like discriminative-stimulus effects, and that they, very likely, would attenuate the discriminative-stimulus effects of psychostimulants. In agreement with this hypothesis, neither the A 1 receptor agonist CPA nor the A 2A receptor agonist CGS 21680 produced significant substitution for the methamphetamine-training stimulus, but they also did not produce any shifts in the methamphetamine dose-response curve. Unexpectedly, CGS 21680 produced significant partial substitution (50% of drug-lever selection) for the cocaine-training stimulus, although this occurred at doses that decreased rates of responding, making it difficult to evaluate the effects. Both CPA and CGS 21680 potentiated the discriminative-stimulus actions of cocaine, as shown by significant leftward shifts of the cocaine dose-response curve. Although substitution for the cocaine-training stimulus was only significant for the A 2A receptor agonist, the common potentiating effects of both CPA and CGS 21680 on cocaine discrimination suggest that these effects could be explained Fig. 6 . Left panels, METH dose-response curves after intraperitoneal pretreatment with 1.0 ml/kg of vehicle or 0.056 mg/kg CGS 21680 (n ϭ 6). Right panels, cocaine doseresponse curves after pretreatment with 1.0 ml/kg of vehicle or 0.056 mg/kg CGS 21680 (n ϭ 6). Data are expressed as mean Ϯ S.E. Numbers in parentheses indicate the number of rats that completed at least one fixed ratio during the session over the total number of rats in which the combination was tested. Other details are as described in Fig. 2 .
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at ASPET Journals on October 25, 2017 jpet.aspetjournals.org by the ability of cocaine, but not methamphetamine, to increase extracellular concentrations of adenosine. In fact, repeated cocaine treatment (which is also a condition present in drug-discrimination experiments) produces an increase in extracellular adenosine tone in the ventral tegmental area (Fiorillo and Williams, 2000) . On the other hand, the acute systemic administration of d-amphetamine does not significantly modify the striatal extracellular concentration of adenosine (Herrera-Marschitz et al., 1994) . Nevertheless, more experiments need to be carried out to establish differential effects of methamphetamine and cocaine on the extracellular levels of adenosine in the brain.
In conclusion, the present findings obtained with selective drugs at A 1 and A 2A adenosine receptors provide evidence that adenosinergic mediation or modulation of the discriminative-stimulus effects of methamphetamine and cocaine involves both receptor subtypes. A 1 and A 2A adenosine receptors appear to play important, although differential, roles in the discriminative-stimulus effects of the studied psychostimulants. Interestingly, adenosine receptor agonists produced different discriminative-stimulus effects in cocaineversus methamphetamine-trained rats and modulated only the discriminative-stimulus effects of cocaine. Neurobiological mechanisms responsible for these effects remain to be determined.
